Downregulation of ASPP2 improves hepatocellular carcinoma cells survival via promoting BECN1-dependent autophagy initiation

Cell Death and Disease

Volumn 7, Issue 12, 2016, Pages

  Chen, Rui ^a   Wang, Hao ^a   Liang, Beibei ^b   Liu, Guoke ^a   Tang, Min ^a   Jia, Rongjie ^a   Fan, Xiaoyu ^a,c   Jing, Wei ^d   Zhou, Xuyu ^d   Wang, Huajing ^a   Yang, Yang ^a   Wei, Huafeng ^e   Li, Bohua ^a   Zhao, Jian ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF MEDICINE AND HEALTH SCIENCES   (China)

^c LANZHOU GENERAL HOSPITAL   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANKYRIN REPEAT CONTAINING SH3 DOMAIN CONTAINING AND PROLINE RICH REGION CONTAINING PROTEIN 2; BECLIN 1; CHLOROQUINE; FLUOROURACIL; I KAPPA B KINASE ALPHA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE CATALYTIC SUBUNIT TYPE 3; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; PROTEIN BINDING; TP53BP2 PROTEIN, HUMAN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CANCER GROWTH; CANCER INHIBITION; CANCER PATIENT; CARCINOGENESIS; CELL NUCLEUS; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG RESISTANCE; ENZYME ACTIVE SITE; ENZYME PHOSPHORYLATION; GENE SILENCING; GENETIC TRANSCRIPTION; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; TRANSACTIVATION; ANIMAL; BAGG ALBINO MOUSE; CARCINOMA, HEPATOCELLULAR; GENETICS; HUMAN; IMMUNOPRECIPITATION; LIVER NEOPLASMS; METABOLISM; NUDE MOUSE; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; BECLIN-1; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL SURVIVAL; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE SILENCING; HUMANS; IMMUNOPRECIPITATION; LIVER NEOPLASMS; MALE; MICE, INBRED BALB C; MICE, NUDE; PROTEIN BINDING; TRANSCRIPTION FACTOR RELA; TRANSCRIPTIONAL ACTIVATION;

EID: 85015942408     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2016.407     Document Type: Article

References (30)

1. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 147: 728–741.
2. Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther 2011; 11: 157–168.
3. Hensley K, Harris-White ME. Redox regulation of autophagy in healthy brain and neurodegeneration. Neurobiol Dis 2015; 84: 50–59.
4. Lapierre LR, Kumsta C, Sandri M, Ballabio A, Hansen M. Transcriptional and epigenetic regulation of autophagy in aging. Autophagy 2015; 11: 867–880.
5. Kenific CM, Debnath J. Cellular and metabolic functions for autophagy in cancer cells. Trends Cell Biol 2015; 25: 37–45.
6. Jiang X, Overholtzer M, Thompson CB. Autophagy in cellular metabolism and cancer. J Clin Invest 2015; 125: 47–54.
7. Cui J, Gong Z, Shen HM. The role of autophagy in liver cancer: molecular mechanisms and potential therapeutic targets. Biochim Biophys Acta 2013; 1836: 15–26.
8. Dash S, Chava S, Chandra PK, Aydin Y, Balart LA, Wu T. Autophagy in hepatocellular carcinomas: from pathophysiology to therapeutic response. Hepat Med 2016; 8: 9–20.
9. Liang XH, Jackson S, Seaman M, Brown K, Kempkes B, Hibshoosh H et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402: 672–676.
10. Yue Z, Jin S, Yang C, Levine AJ, Heintz N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc Natl Acad Sci USA 2003; 100: 15077–15082.
11. Wirawan E, Lippens S, Vanden Berghe T, Romagnoli A, Fimia GM, Piacentini M et al. Beclin1: a role in membrane dynamics and beyond. Autophagy 2012; 8: 6–17.
12. Toton E, Lisiak N, Sawicka P, Rybczynska M. Beclin-1 and its role as a target for anticancer therapy. J Physiol Pharmacol 2014; 65: 459–467.
13. Tang H, Da L, Mao Y, Li Y, Li D, Xu Z et al. Hepatitis B virus X protein sensitizes cells to starvation-induced autophagy via up-regulation of beclin 1 expression. Hepatology 2009; 49: 60–71.
14. Song H, Xia SL, Liao C, Li YL, Wang YF, Li TP et al. Genes encoding Pir51, Beclin 1, RbAp48 and aldolase b are up or down-regulated in human primary hepatocellular carcinoma. World J Gastroenterol 2004; 10: 509–513.
15. Kiyono K, Suzuki HI, Matsuyama H, Morishita Y, Komuro A, Kano MR et al. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells. Cancer Res 2009; 69: 8844–8852.
16. Song J, Guo X, Xie X, Zhao X, Li D, Deng W et al. Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma. J Cell Biochem 2011; 112: 3406–3420.
17. Al-Shenawy HA. Expression of Beclin-1, an autophagy-related marker, in chronic hepatitis and hepatocellular carcinoma and its relation with apoptotic markers. APMIS 2016; 124: 229–237.
18. Trigiante G, Lu X. ASPP [corrected] and cancer. Nat Rev Cancer 2006; 6: 217–226.
19. Zhao J, Wu G, Bu F, Lu B, Liang A, Cao L et al. Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region-containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 2010; 51: 142–153.
20. Wang Y, Wang XD, Lapi E, Sullivan A, Jia W, He YW et al. Autophagic activity dictates the cellular response to oncogenic RAS. Proc Natl Acad Sci USA 2012; 109: 13325–13330.
21. Copetti T, Bertoli C, Dalla E, Demarchi F, Schneider C. p65/RelA modulates BECN1 transcription and autophagy. Mol Cell Biol 2009; 29: 2594–2608.
22. Yang JP, Hori M, Takahashi N, Kawabe T, Kato H, Okamoto T. NF-kappaB subunit p65 binds to 53BP2 and inhibits cell death induced by 53BP2. Oncogene 1999; 18: 5177–5186.
23. Chen LF, Greene WC. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 2004; 5: 392–401.
24. Behrends C, Sowa ME, Gygi SP, Harper JW. Network organization of the human autophagy system. Nature 2010; 466: 68–76.
25. Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M et al. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis 2013; 4: e838.
26. Chen N, Karantza V. Autophagy as a therapeutic target in cancer. Cancer Biol Ther 2014; 11: 157–168.
27. Tordella L, Koch S, Salter V, Pagotto A, Doondeea JB, Feller SM et al. ASPP2 suppresses squamous cell carcinoma via RelA/p65-mediated repression of p63. Proc Natl Acad Sci USA 2013; 110: 17969–17974.
28. Itakura E, Kishi C, Inoue K, Mizushima N. Beclin 1 forms two distinct phosphatidylinositol 3-kinase complexes with mammalian Atg14 and UVRAG. Mol Biol Cell 2008; 19: 5360–5372.
29. Matsunaga K, Saitoh T, Tabata K, Omori H, Satoh T, Kurotori N et al. Two Beclin 1-binding proteins, Atg14L and Rubicon, reciprocally regulate autophagy at different stages. Nat Cell Biol 2009; 11: 385–396.
30. Liu K, Shi Y, Guo X, Wang S, Ouyang Y, Hao M et al. CHOP mediates ASPP2-induced autophagic apoptosis in hepatoma cells by releasing Beclin-1 from Bcl-2 and inducing nuclear translocation of Bcl-2. Cell Death Dis 2014; 5: e1323.